Home Thiazoles 1001419-37-9
1001419-37-9,MFCD16877433
Catalog No.:AA00010F

1001419-37-9 | tert-Butyl (5-(hydroxymethyl)thiazol-2-yl)carbamate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
99%
in stock  
$67.00   $47.00
- +
250mg
99%
in stock  
$153.00   $108.00
- +
500mg
99%
in stock  
$256.00   $180.00
- +
1g
99%
in stock  
$426.00   $298.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00010F
Chemical Name:
tert-Butyl (5-(hydroxymethyl)thiazol-2-yl)carbamate
CAS Number:
1001419-37-9
Molecular Formula:
C9H14N2O3S
Molecular Weight:
230.2841
MDL Number:
MFCD16877433
SMILES:
OCc1cnc(s1)NC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
230  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/9465,2008,A1Locationinpatent:Page/Pagecolumn43

[2]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2011/130459,2011,A1Locationinpatent:Page/Pagecolumn65

[3]CurrentPatentAssignee:MERCK&COINC-WO2014/99578,2014,A1Locationinpatent:Page/Pagecolumn50

[4]CurrentPatentAssignee:MERCKKGAA-WO2014/159234,2014,A1Locationinpatent:Page/Pagecolumn57

[1]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-US2006/35908,2006,A1Locationinpatent:Page/Pagecolumn116

[2]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2008/9465,2008,A1Locationinpatent:Page/Pagecolumn42

[3]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2011/130459,2011,A1Locationinpatent:Page/Pagecolumn64;65

[1]CurrentPatentAssignee:MERCK&COINC-US2011/166124,2011,A1Locationinpatent:Page/Pagecolumn42

[2]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-US2006/35908,2006,A1Locationinpatent:Page/Pagecolumn116

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/101949,2010,A1Locationinpatent:Page/Pagecolumn136

[1]CurrentPatentAssignee:MERCK&COINC-WO2014/99578,2014,A1Locationinpatent:Page/Pagecolumn49-50

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/59839,2011,A1Locationinpatent:Page/Pagecolumn68

[3]CurrentPatentAssignee:MERCK&COINC-US2011/166124,2011,A1Locationinpatent:Page/Pagecolumn42

[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/101949,2010,A1Locationinpatent:Page/Pagecolumn135;136

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2013/59587,2013,A1Locationinpatent:Page/Pagecolumn187;188

[6]CurrentPatentAssignee:MERCKKGAA-WO2014/159234,2014,A1Locationinpatent:Page/Pagecolumn57

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-EP2768509,2017,B1Locationinpatent:Paragraph0726;0728

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1001419-37-9 Molecular Formula|1001419-37-9 MDL|1001419-37-9 SMILES|1001419-37-9 tert-Butyl (5-(hydroxymethyl)thiazol-2-yl)carbamate